142 related articles for article (PubMed ID: 16630135)
1. Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma.
Kuboshima M; Shimada H; Liu TL; Nomura F; Takiguchi M; Hiwasa T; Ochiai T
Cancer Sci; 2006 May; 97(5):380-6. PubMed ID: 16630135
[TBL] [Abstract][Full Text] [Related]
2. Detection of anti-CUEC-23 antibodies in serum of patients with esophageal squamous cell carcinoma: a possible new serum marker for esophageal cancer.
Shimada H; Kagaya A; Shiratori T; Nomura F; Takiguchi M; Matsubara H; Hiwasa T
J Gastroenterol; 2009; 44(7):691-6. PubMed ID: 19407926
[TBL] [Abstract][Full Text] [Related]
3. Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma.
Shimada H; Shiratori T; Yasuraoka M; Kagaya A; Kuboshima M; Nomura F; Takiguchi M; Ochiai T; Matsubara H; Hiwasa T
BMC Cancer; 2009 Jul; 9():232. PubMed ID: 19604354
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.
Kuboshima M; Shimada H; Liu TL; Nakashima K; Nomura F; Takiguchi M; Hiwasa T; Ochiai T
Int J Oncol; 2006 Feb; 28(2):463-8. PubMed ID: 16391802
[TBL] [Abstract][Full Text] [Related]
5. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
6. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma.
Nakashima K; Shimada H; Ochiai T; Kuboshima M; Kuroiwa N; Okazumi S; Matsubara H; Nomura F; Takiguchi M; Hiwasa T
Int J Cancer; 2004 Dec; 112(6):1029-35. PubMed ID: 15386348
[TBL] [Abstract][Full Text] [Related]
7. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.
Shimada H; Takeda A; Arima M; Okazumi S; Matsubara H; Nabeya Y; Funami Y; Hayashi H; Gunji Y; Suzuki T; Kobayashi S; Ochiai T
Cancer; 2000 Oct; 89(8):1677-83. PubMed ID: 11042560
[TBL] [Abstract][Full Text] [Related]
8. Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma.
Shimada H; Kuboshima M; Shiratori T; Nabeya Y; Takeuchi A; Takagi H; Nomura F; Takiguchi M; Ochiai T; Hiwasa T
Int J Oncol; 2007 Jan; 30(1):97-103. PubMed ID: 17143517
[TBL] [Abstract][Full Text] [Related]
9. NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers.
Oshima Y; Shimada H; Yajima S; Nanami T; Matsushita K; Nomura F; Kainuma O; Takiguchi N; Soda H; Ueda T; Iizasa T; Yamamoto N; Yamamoto H; Nagata M; Yokoi S; Tagawa M; Ohtsuka S; Kuwajima A; Murakami A; Kaneko H
J Gastroenterol; 2016 Jan; 51(1):30-4. PubMed ID: 25906289
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy.
Blanchard P; Quero L; Pacault V; Schlageter MH; Baruch-Hennequin V; Hennequin C
BMC Cancer; 2012 Mar; 12():119. PubMed ID: 22448886
[TBL] [Abstract][Full Text] [Related]
11. Serological identification of tumor antigens of esophageal squamous cell carcinoma.
Shimada H; Nakashima K; Ochiai T; Nabeya Y; Takiguchi M; Nomura F; Hiwasa T
Int J Oncol; 2005 Jan; 26(1):77-86. PubMed ID: 15586227
[TBL] [Abstract][Full Text] [Related]
12. Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: correlation with clinicopathologic features and tumor markers.
Shimada H; Nakajima K; Ochiai T; Koide Y; Okazumi SI; Matsubara H; Takeda A; Miyazawa Y; Arima M; Isono K
Oncol Rep; 1998; 5(4):871-4. PubMed ID: 9625835
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of serum midkine in detecting esophageal squamous cell carcinoma.
Shiratori F; Ito M; Yajima S; Suzuki T; Oshima Y; Nanami T; Funahashi K; Shimada H
Esophagus; 2019 Jul; 16(3):246-251. PubMed ID: 30778774
[TBL] [Abstract][Full Text] [Related]
14. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
16. Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma.
Shimada H; Shiratori T; Takeda A; Matsushita K; Okazumi S; Akutsu Y; Matsubara H; Nomura F; Ochiai T
World J Surg; 2009 Feb; 33(2):272-7. PubMed ID: 19052812
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Tagawa M; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
Cancer Sci; 2003 Jul; 94(7):628-32. PubMed ID: 12841873
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating anti-p53 antibodies in esophageal cancer patients.
Hagiwara N; Onda M; Miyashita M; Sasajima K
J Nippon Med Sch; 2000 Apr; 67(2):110-7. PubMed ID: 10754600
[TBL] [Abstract][Full Text] [Related]
19. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
[TBL] [Abstract][Full Text] [Related]
20. Circulating anti-p53 antibodies in esophageal cancer patients.
Kozłowski M; Kovalchuk O; Nikliński J; Chyczewski L; Starosławska E; Ciechański A; Dabrowski A; Niklińska W; Dziegielewski P; Lapuć G; Wallner G; Laudański J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():173-4. PubMed ID: 11820593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
